Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan
· Delayed Price · Currency is TWD
Full Chart
Watchlist
Compare
68.10
-0.20 (-0.29%)
At close: May 28, 2026
Overview
Financials
Statistics
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Semi-Annual
TTM
TPEX:7871 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
FY 2023
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Cash & Equivalents
863.36
88.12
30.53
Cash & Short-Term Investments
863.36
88.12
30.53
Cash Growth
879.74%
188.60%
-
Accounts Receivable
0.1
2.4
1.43
Other Receivables
14.18
7.53
0.26
Receivables
14.28
9.92
1.69
Prepaid Expenses
6.15
1.25
0.79
Other Current Assets
-
0.2
0.01
Total Current Assets
883.79
99.49
33.03
Property, Plant & Equipment
19.95
26.69
22.78
Long-Term Investments
-
-
0.29
Other Intangible Assets
15.61
12.59
14.4
Other Long-Term Assets
10.83
9.86
10.01
Total Assets
930.17
148.63
80.51
Accrued Expenses
-
18.6
51.13
Short-Term Debt
-
1,345
731.92
Current Portion of Long-Term Debt
-
6.5
6.5
Current Portion of Leases
4.36
4.16
4.91
Current Income Taxes Payable
18.86
3.93
3.68
Other Current Liabilities
64.89
13.19
13.86
Total Current Liabilities
88.11
1,392
812
Long-Term Debt
5.42
11.92
18.42
Long-Term Leases
8.66
13.02
16.61
Total Liabilities
102.18
1,417
847.02
Common Stock
1,343
0.7
0.69
Additional Paid-In Capital
-
15.24
11.9
Retained Earnings
-2,311
-1,205
-764.54
Comprehensive Income & Other
1,797
-78.97
-14.56
Shareholders' Equity
827.99
-1,268
-766.51
Total Liabilities & Equity
930.17
148.63
80.51
Total Debt
18.44
1,381
778.35
Net Cash (Debt)
844.93
-1,293
-747.82
Net Cash Per Share
10.71
-58.42
-9.36
Filing Date Shares Outstanding
132.5
22.41
21.86
Total Common Shares Outstanding
132.5
22.41
21.86
Working Capital
795.68
-1,292
-778.97
Book Value Per Share
6.25
-56.57
-35.07
Tangible Book Value
812.38
-1,280
-780.92
Tangible Book Value Per Share
6.13
-57.13
-35.73